Reports
Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
The global veterinary drugs market reached a value of about USD 16 billion in 2020. The market for veterinary drugs is being driven by the development of new drugs and increasing ownership of animals. The market is further expected to grow at a CAGR of 6.2% in the forecast period of 2022-2027 to reach a value of approximately USD 23 billion by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The increasing ownership of animals, both companions and livestock, is rapidly boosting the market growth for veterinary drugs. The ownership of animals comes with the responsibility of keeping them healthy; therefore, the growing developments in veterinary drugs is supporting the growth of the market. Animal derivatives such as milk, eggs, among others, are driving the ownership of livestock and indirectly boosting the growth of the veterinary drugs industry. The increasing use of animal derivatives prompts the owner to keep the livestock consistently treated to prevent diseases, parasites, etc., thereby aiding the industry growth. The high adoption rate of companion animals is a driving factor for the growth of the veterinary drugs industry due to owners being highly careful and preventive of any medical problems.
Veterinary drugs are essential for the life of animals, as they are used to treat diseases, parasites etc., after an accurate diagnosis. General veterinary drugs are used to examine pharmacology, metabolic safety, toxicology, food safety, etc., whilst specialized drugs are also available to treat high order diseases. Respective authorities of nations establish stringent guidelines for the administration and production of these drugs as the growing need for these drugs is becoming prevalent. The vital necessity for owners of animals, both companions and livestock, to keep their animals healthy is highly significant for the veterinary drugs industry.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on product, the market is divided into:
Biologics is further divided on the basis of type into vaccines and others, whereas, pharmaceuticals is further divided on the basis of type into parasiticides, anti-infectives, anti-inflammatory, analgesics, among others.
Based on animal, the market is bifurcated into:
Based on route of administration, the market is categorised into:
Based on distribution channel, the market is segmented into:
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The continuous advancements in the veterinary sector, such as wearable devices to monitor animal health, minimally invasive surgical procedures, among others, are supporting the growth of this market. The developments in the effectiveness of drugs as well as the introduction of new drugs to treat diseases are bolstering the growth of the industry. The market growth is significantly boosted by the rising demand for parasiticides, as more and more livestock owners are focusing on animal health to boost their business in animal derivatives. Growing animal health awareness initiatives by governments and the private sector, along with sponsoring of different veterinary key players are predicted to have a high growth rate during the forecast period.
The report gives a detailed analysis of the following key players in the global veterinary drugs market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2020 |
Historical Period | 2017-2021 |
Forecast Period | 2022-2027 |
Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Animal, Route of Administration, Distribution Channel, Region |
Breakup by Product | Biologics, Pharmaceuticals, Medicinal Feed Additives |
Breakup by Animal | Companion, Livestock |
Breakup by Route of Administration | Oral, Parenteral, Topical |
Breakup by Distribution Channel | Veterinary Hospitals and Clinics, Pharmacies and Drug Stores, Online, Others |
Breakup by Region | North America, Latin America, Europe, Middle East and Africa, Asia Pacific |
Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
Companies Covered | Bayer AG, Vetoquinol S.A., Boehringer Ingelheim International GmbH, Kindred Biosciences, Inc., Zoetis Inc., Others |
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always strive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Veterinary Drugs Market Analysis
8.1 Key Industry Highlights
8.2 Global Veterinary Drugs Historical Market (2017-2021)
8.3 Global Veterinary Drugs Market Forecast (2022-2027)
8.4 Global Veterinary Drugs Market by Product
8.4.1 Biologics
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.1.4 Market by Type
8.4.1.4.1 Vaccines
8.4.1.4.1.1 Market Share
8.4.1.4.1.2 Historical Trend (2017-2021)
8.4.1.4.1.3 Forecast Trend (2022-2027)
8.4.1.4.2 Others
8.4.2 Pharmaceuticals
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.4.2.4 Market by Type
8.4.2.4.1 Parasiticides
8.4.2.4.1.1 Market Share
8.4.2.4.1.2 Historical Trend (2017-2021)
8.4.2.4.1.3 Forecast Trend (2022-2027)
8.4.2.4.2 Anti-Infectives
8.4.2.4.2.1 Market Share
8.4.2.4.2.2 Historical Trend (2017-2021)
8.4.2.4.2.3 Forecast Trend (2022-2027)
8.4.2.4.3 Anti-Inflammatory
8.4.2.4.3.1 Market Share
8.4.2.4.3.2 Historical Trend (2017-2021)
8.4.2.4.3.3 Forecast Trend (2022-2027)
8.4.2.4.4 Analgesics
8.4.2.4.4.1 Market Share
8.4.2.4.4.2 Historical Trend (2017-2021)
8.4.2.4.4.3 Forecast Trend (2022-2027)
8.4.2.4.5 Others
8.4.3 Medicinal Feed Additives
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2017-2021)
8.4.3.3 Forecast Trend (2022-2027)
8.5 Global Veterinary Drugs Market by Animal
8.5.1 Companion
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Livestock
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.6 Global Veterinary Drugs Market by Route of Administration
8.6.1 Oral
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2017-2021)
8.6.1.3 Forecast Trend (2022-2027)
8.6.2 Parenteral
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2017-2021)
8.6.2.3 Forecast Trend (2022-2027)
8.6.3 Topical
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2017-2021)
8.6.3.3 Forecast Trend (2022-2027)
8.7 Global Veterinary Drugs Market by Distribution Channel
8.7.1 Veterinary Hospitals and Clinics
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2017-2021)
8.7.1.3 Forecast Trend (2022-2027)
8.7.2 Pharmacies and Drug Stores
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2017-2021)
8.7.2.3 Forecast Trend (2022-2027)
8.7.3 Online
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2017-2021)
8.7.3.3 Forecast Trend (2022-2027)
8.7.4 Others
8.8 Global Veterinary Drugs Market by Region
8.8.1 Market Share
8.8.1.1 North America
8.8.1.2 Europe
8.8.1.3 Asia Pacific
8.8.1.4 Latin America
8.8.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Bayer AG
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Vetoquinol S.A.
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Boehringer Ingelheim International GmbH
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Kindred Biosciences, Inc.
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Zoetis Inc.
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Global Veterinary Drugs Market: Key Industry Highlights, 2016 and 2026
2. Global Veterinary Drugs Historical Market: Breakup by Product (USD Billion), 2017-2021
3. Global Veterinary Drugs Market Forecast: Breakup by Product (USD Billion), 2022-2027
4. Global Veterinary Drugs Historical Market: Breakup by Animal (USD Billion), 2017-2021
5. Global Veterinary Drugs Market Forecast: Breakup by Animal (USD Billion), 2022-2027
6. Global Veterinary Drugs Historical Market: Breakup by Route of Administration (USD Billion), 2017-2021
7. Global Veterinary Drugs Market Forecast: Breakup by Route of Administration (USD Billion), 2022-2027
8. Global Veterinary Drugs Historical Market: Breakup by Distribution Channel (USD Billion), 2017-2021
9. Global Veterinary Drugs Market Forecast: Breakup by Distribution Channel (USD Billion), 2022-2027
10. Global Veterinary Drugs Historical Market: Breakup by Region (USD Billion), 2017-2021
11. Global Veterinary Drugs Market Forecast: Breakup by Region (USD Billion), 2022-2027
12. North America Veterinary Drugs Historical Market: Breakup by Country (USD Billion), 2017-2021
13. North America Veterinary Drugs Market Forecast: Breakup by Country (USD Billion), 2022-2027
14. Europe Veterinary Drugs Historical Market: Breakup by Country (USD Billion), 2017-2021
15. Europe Veterinary Drugs Market Forecast: Breakup by Country (USD Billion), 2022-2027
16. Asia Pacific Veterinary Drugs Historical Market: Breakup by Country (USD Billion), 2017-2021
17. Asia Pacific Veterinary Drugs Market Forecast: Breakup by Country (USD Billion), 2022-2027
18. Latin America Veterinary Drugs Historical Market: Breakup by Country (USD Billion), 2017-2021
19. Latin America Veterinary Drugs Market Forecast: Breakup by Country (USD Billion), 2022-2027
20. Middle East and Africa Veterinary Drugs Historical Market: Breakup by Country (USD Billion), 2017-2021
21. Middle East and Africa Veterinary Drugs Market Forecast: Breakup by Country (USD Billion), 2022-2027
22. Major Importing Countries by Volume (2020)
23. Major Exporting Countries by Volume (2020)
24. Major Importing Countries by Value (2020)
25. Major Exporting Countries by Value (2020)
26. Global Veterinary Drugs Market Structure
In 2020, the global veterinary drugs market attained a value of nearly USD 16 billion.
The market is projected to grow at a CAGR of 6.2% between 2021 and 2026.
The market is estimated to witness healthy growth in the forecast period of 2022-2027 to reach USD 23 billion by 2026.
The major drivers of the market include the development of new drugs and increasing ownership of animals.
The veterinary drugs market is being aided by developments in the effectiveness of drugs as well as the introduction of new drugs to treat diseases.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Biologics, pharmaceuticals, and medicinal feed additives are the leading products in the industry. Biologics are further divided into vaccines and others. Pharmaceuticals are further segmented into parasiticides, anti-infectives, anti-inflammatory, and analgesics, among others.
Companion and livestock are the leading animals in the industry.
Companion and livestock are the animals covered in the industry.
Oral, parental, and topical are the leading route of administration in the industry.
Veterinary, hospitals and clinics, pharmacies and drug stores, and online, among others are the leading distribution channels in the industry.
The major players in the industry are Bayer AG, Vetoquinol S.A., Boehringer Ingelheim International GmbH, Kindred Biosciences, Inc., and Zoetis Inc., among others.
The global veterinary drugs market attained a value of USD 16 billion in 2020, driven by the development of new drugs and increasing ownership of animals. The market is expected to witness further growth in the forecast period of 2022-2027, growing at a CAGR of 6.2%. The market is projected to reach USD 23 billion by 2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its products, the veterinary drugs industry can be segmented into biologics, pharmaceuticals, and medicinal feed additives. On the basis of animals, the market is divided into companion and livestock. On the basis of route of administration, the market is divided into oral, parental, and topical. Based on distribution channel, the market is divided into veterinary, hospitals and clinics, pharmacies and drug stores, and online, among others. The major regional markets for veterinary drugs are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Bayer AG, Vetoquinol S.A., Boehringer Ingelheim International GmbH, Kindred Biosciences, Inc., and Zoetis Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.